DiscoverEditors in ConversationThe First OTC Syphilis Test: Clinical Performance and Impact
The First OTC Syphilis Test: Clinical Performance and Impact

The First OTC Syphilis Test: Clinical Performance and Impact

Update: 2025-10-25
Share

Description

Treponema pallidum, the causative agent of syphilis, has been around for what seems like forever, causing major outbreaks throughout the millennia and continuing to spread at high rates, globally, into today. When it comes to diagnostic testing, some tests like RPR and VDRL have stood the test of time, having been implemented in the late 1930s and 1940s, and are now used in combination with contemporary methods like EIAs and chemiluminescent assays as the reference standard method to diagnosis syphilis cases. New approaches to screening and diagnosis are needed, however, to increase test access and ultimately case identification and treatment. 

Guests:

  • Dr. Kevin Clark
  • Dr. Jody Berry

Links: 

This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Romney Humphries, Ph.D., D(ABMM). 

Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript.

Become an ASM member to receive up to 50% off publishing fees when you publish in JCM or any of the ASM journals. Sign up at asm.org/joinasm.

 

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

The First OTC Syphilis Test: Clinical Performance and Impact

The First OTC Syphilis Test: Clinical Performance and Impact

Elitza S. Theel, Romney Humphries, Kevin Clark, Jody Berry